Skip to content

Immunology of endometrium in heavy menstrual bleeding

Quantitative Assessment of Immune cells in the endometrial tissue in women with heavy menstrual bleeding and in those with normal cycles: A Cross Sectional Comparative Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067502
Enrollment
100
Registered
2024-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women visiting obstetrics and gynecology OPD in AIIMS Bibinaga with heavy menstrual bleeding without a structural cause.

Exclusion criteria

Exclusion criteria: 1) Samples displaying evidence of hyperplasia or atypia on microscopic evaluation. 2) Samples with tissue that are inadequate for further immunohistochemical evaluation 3) Patients with pelvic inflammatory disease or any other conditions affecting the immunity like autoimmune diseases. 4) Patients on immune modifying drugs.

Design outcomes

Primary

MeasureTime frame
To compare the alterations in the number of uterine natural killer cells, T cells and macrophages in the endometrial biopsy specimens of women with normal menstrual cycles and those with heavy menstrual bleeding.Timepoint: At the time of Endometrial biopsy.

Secondary

MeasureTime frame
To compare the expression of immunohistochemistry in uterine natural killer cells, T cells and macrophages in the endometrial biopsy specimens of women with heavy menstrual bleeding and correlate this with the severity of clinical symptoms in patients with HMB.Timepoint: On histopathology slides after endometrial biopsy

Countries

India

Contacts

Public ContactMishu Mangla

All India Institute of Medical Sciences

mishusingla83@gmail.com09988805850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026